Johnson & Johnson fined record ruling for its part in Oklahoma’s ‘opioid crisis’

By Becky Bargh | Published: 27-Aug-2019
Regulatory Finance

The state’s Attorney General said the firm had built its billion dollar brand on the back of “greed” and “suffering of innocent people”

You need to be a subscriber to read this article.
Click here to find out more.

An Oklahoma judge has ordered Johnson & Johnson (J&J) to pay US$572m (£468m) for its role in the state’s opioid crisis.

After seven weeks, judge Thad Balkman determined the personal care giant and drug supplier ran a “false,

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Johnson and Johnson
See more

You may also like

Skin Care

J&J to hold 9.5% stake in consumer health spinoff Kenvue following share exchange

Read more
The multinational launched the exchange offer in July in a bid to take its hands off the Kenvue reins

Trending Articles

  1. L’Oréal USA promotes Silvia Galfo to President of Luxe Division Galfo, previously Chief Growth Officer of the beauty group’s US subsidiary, will replace Megan Grant
  2. Give Back Beauty lands Mercedes-Benz fragrance licence deal The group will now create, produce and distribute Mercedes-Benz fragrances after acquiring the automotive brand’s licence owner INCC Parfums
  3. The Body Shop exploring deal to slash tax bill The deal is dependent on whether The Body Shop can exit administration and return to profitability, which could potentially reduce its corporation tax in the future
  4. Nivea helps push Beiersdorf sales to €4.9 billion in H1 Sun protection was pinpointed as a strong performance segment for the German giant's Nivea, Eucerin and Aquaphor brands
  5. Lawsuits mount against Givaudan, Firmenich, IFF and Symrise amid fragrance antitrust investigation Texan business Crimson Candle Supplies leads US-based scented products companies in the latest class action filed against the fragrance giants

Upcoming event

Cosmetic Product Safety Assessment E-Training: Starting the Assessment

19 April 2024 | Virtual See all

You may also like

Skin Care

J&J to hold 9.5% stake in consumer health spinoff Kenvue following share exchange

The multinational launched the exchange offer in July in a bid to take its hands off the Kenvue reins
Regulatory

Johnson & Johnson to appeal $19 million owed to California cancer patient

The talc cancer trial involving 24-year-old Emory Hernandez Valadez was the first faced by J&J since its bankruptcy filing
Regulatory

Johnson & Johnson faces first new talc cancer trial since bankruptcy filing

Judge overseeing LTL Management’s Chapter 11 has allowed the trial to go ahead, as 24-year-old cancer patient Anthony Hernandez Valadez does not have long to live
You need to be a subscriber to read this article.
Click here to find out more.
Sustainability

Top 50 beauty brands 2023: Which is the world’s biggest brand?

L’Oréal has retained its status as the world’s most valuable beauty brand on Brand Finance’s league table, but did its value rise or dive in 2023?
Body Care

Johnson & Johnson readies IPO for Kenvue consumer health business

The subsidiary could raise as much as $3.5 billion via the sale of 151,204,000 shares of its common stock
Regulatory

US judge pauses J&J talc trials, but healthcare giant may face new suits

The 60-day freeze advances J&J’s second attempt to settle cases through subsidiary LTL Management’s bankruptcy proceedings
Regulatory

J&J's first quarter earnings plummet following $6.9 billion talc litigation charge

J&J originally proposed a $8.9bn settlement to resolve its ongoing talc litigation woes, and its subsidiary LTL Management has refiled for Chapter 11 bankruptcy
Subscribe now